The 2026 Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS) arrived days after CMS finalized its 2027 payment rules, and the timing shaped every conversation. Across the business, bundled payment, practice model, and AI sessions, three forces kept coming up: shrinking professional fees, mandatory bundles that turn outcomes into a payment issue, and AI tools that are starting to take work off care teams' plates rather than just assist with it.
Here are the themes that stood out to our team from the podium and from our conversations with surgeons and program leaders.
Fee Compression Is Pushing Surgeons Toward Ownership
The CY 2027 Physician Fee Schedule final rule cut the work RVUs for primary hip and knee replacement from 19.11 to 16.70, and the conversion factor fell 2.31% for most clinicians. Presenters who modeled the full professional fee estimated a total decline of roughly 17% to 18% for 2027. At the same time, CMS projects ASC payments for total hip and knee rising about 4% to 5% under the final OPPS/ASC rule. Speaker after speaker drew the same conclusion: for independent surgeons, facility ownership is becoming a viability strategy, not just an investment.
Dr. Michael Meneghini, presenting on Indiana Orthopedic Institute's strategy, described a market consolidating into two models, private practice with facility ownership or employment, with a long-term roadmap running from fee-for-service toward global musculoskeletal risk and a connected, AI-enabled ASC ecosystem. In the independent practice session, Dr. DeCook made the case for specializing and standardizing around a single-specialty ASC that can run 12 to 20 joints per day, compared with about 8 in a typical setting. A panel responding to the CMS cuts added the economics: professional fees are a small slice of total episode payment, and a lean, joints-only ASC can generate meaningful margin per Medicare case. Their advice to surgeons was blunt: know your numbers, down to your explanations of benefits, and plan for succession.
For ASC-owning surgeons, ownership brings new accountability, too. The outpatient THA/TKA PRO-PM moves to mandatory pre-op data collection for ASCs in October 2027, so the same surgeons buying into facilities are inheriting a PROMs reporting obligation.
Mandatory Bundles Make Outcomes a Payment Issue
CJR-X, which begins nationwide on January 1, 2028 with 90-day episodes, and TEAM, which is already underway regionally with 30-day episodes, both hold hospitals accountable for cost and quality, and both factor patient-reported outcomes into performance. The sessions made clear that the easy savings are gone.
Dr. Saxena presented a review of Rothman Orthopaedics' bundled payments. Under BPCI Advanced, Rothman reported a loss despite cutting episode costs by about a third. Its commercial bundles saved about $78 million over nine years, but that required more than ten nurse navigators, dedicated analysts, and deliberate matching of patients to the lowest appropriate site of service, and the savings peaked in 2021 to 2023 before declining in 2024 and 2025. The lesson for CJR-X: target prices tighten over time, and the infrastructure needed to keep up is expensive.
The underlying tension is that under fee-for-service, prehab and avoided post-acute care are lost revenue; under a bundle, they are savings. Programs living in both worlds at once need care models that make sense under either, and this requires preplanned and thoughtful cooperation with surgeons and practices, who make most of the decisions but are not explicitly accountable for performance.
RTM and PCM Are Real but Narrow Offsets
Surgeons are looking for billable ways to recognize the remote care their care teams already deliver, and a dedicated session covered Principal Care Management (PCM) and remote therapeutic monitoring (RTM). Dr. Dundon walked through the rules carefully. Per the presentation, PCM requires a qualifying chronic condition managed for at least three months, and osteoarthritis alone does not qualify. RTM setup codes may be billed during the global period, but time-based management codes may not. Commercial coverage is uneven, and at least one major commercial payer does not cover RTM.
A modeled 500-joint practice projected about $116,500 in gross RTM and PCM revenue and just over $40,000 net. Programs also need to account for the recently introduced changes: beginning January 1, RTM is limited to established patients and requires an initiating visit, and CMS will require monitoring staff to be employed by the billing practice beginning in 2029.
Surgeon Alignment Is Still the Hardest Problem
Whatever the payment model, success depends on getting surgeons to standardize. Presenters shared practical tools for doing it. Dr. Wendy Wong described a co-management model in which a surgeon LLC bills the hospital hourly for leadership work, plus bonuses tied to quality and efficiency metrics, which paid about $68,000 per surgeon last year. Dr. Ajay Premkumar presented Emory's “Leading from the Inside” framework for driving change inside a health system, built on four questions: What am I afraid of? Who actually signs? What is happening upstairs? Who should say it?
In our own conversations, surgeon leaders described long, incremental standardization efforts and said that peer-comparison data is one of the few levers that consistently moves surgeon behavior. Transparent outcomes by surgeon, and agreed-upon gold-standard pathways, came up again and again.
AI Is Moving From Assisting to Doing
The AI sessions marked a shift in expectations. In the AI in arthroplasty session moderated by Dr. Perricelli, William Long of Hospital for Special Surgery (HSS) presented a voice AI agent that calls patients to collect KOOS Jr. and HOOS Jr. In a study of 935 patients, the agent achieved 69% to 78% PROM completion, compared with 54% to 65% using conventional methods, with 91% and 84% agreement with manually collected scores. Separate HSS research quantified the post-op call burden: about 34,210 nurse practitioner calls in the first 90 days after surgery in 2025, 43% of them about medication and 40% about medical questions.
Other presentations covered AI agents that answer routine post-op questions using surgeon-specific protocols, smart implant monitoring associated with a drop in manipulation under anesthesia from 3.1% to 0.97%, and web-based physical therapy that is safe and effective for most TKA patients. We were also glad to see Force Therapeutics cited from the podium as an example of a digital recovery platform.
In a separate session, Dr. DeCook offered a useful frame: nearly all physician AI usage today is “ask and assist,” but the transformational AI is the kind that deletes a task entirely. That standard applies to everyone building tools for orthopedic care teams.
The Case for Remote Monitoring Keeps Getting Stronger
Research presented at the meeting reinforced why staying connected after discharge matters. A randomized trial of remote monitoring after joint replacement found rehospitalization rates of 3.4% with monitoring versus 12.2% without. Work on periprosthetic joint infection found that when debridement, antibiotics, and implant retention (DAIR) was performed more than 48 hours after symptom onset, the odds of 90-day mortality were 2.93 times higher and the odds of reoperation 22.19 times higher. Catching problems early is not just about patient experience; it changes outcomes.
Presenters also emphasized that alerts alone are not enough. Exception-based care models, with patients sorted into green, yellow, and red tiers and a defined clinical response pathway for each, let a small team focus its time where it matters.
What It Means for Orthopedic Programs
The common thread at AAHKS 2026 was doing more with less: lower professional fees, tighter bundle targets, more outpatient and ASC volume, and more reporting obligations that follow the patient across settings. The programs best positioned for 2027 and 2028 will be the ones that replace manual, headcount-heavy work, from PROM collection to routine post-op calls, with infrastructure that can scale effectively, while giving surgeons the transparent outcomes data they need to align.
Force Therapeutics extends the care team across the full episode of care, from pre-op through recovery, in inpatient, hospital outpatient, and ASC settings. Our partners use condition- and procedure-specific care plans, automated PROMs collection, and remote monitoring with automated gold-standard workflows to keep patients connected and surface the ones who need attention, without adding staff.
To learn more about how leading institutions are preparing for CJR-X, TEAM, and the 2027 payment changes, reach out to the Force team through the form below:


.webp)


